Dr Carmel Loughland

Associate Professor

School of Medicine and Public Health (Public Health)

Career Summary

Biography

Associate Professor Carmel Loughland is a member of the Priority Centre for Translational Neuroscience and Mental Health, and a academic within the Faculty of Medicine and Population Health, University of Newcastle. A/Professor Loughland is also a senior psychologist with several years practical experience as a registered psychologist (Registration No. PS0001366383) and is authorised to supervise intern and registered psychologists, and is also a registered Justice of the Peace (Registration No.129021). A/Professor Loughland obtained her Ph.D from the University of Sydney in 2002. Her research focuses on visuo-cognition deficits, particularly face processing disturbances, in people with schizophrenia and other clinical disorders (i.e., affective disorder, borderline personality disorder, psychopathy). In 2002, she established an eye tracking laboratory purpose built for visual scanpath research at the McAuley Centre, Mater Hospital, Newcastle and has been successful in securing a number of research grants as chief investigator to pursue her projects (totalling $188,720). These included the prestigious US NARSAD Young Investigator Award, Hunter Medical Research Institute (HMRI) Early Career Researcher Award, HMRI Project Grants as well as a NISAD Project Grant and three University of Newcastle Faculty of Health Equipment Grants.

This research has resulted in a number of high quality publications. A/Professor Loughland has been invited to present her research findings at national and international scientific meetings, including keynote speaker and symposium chair invitations, and has been invited to present at several community mental health forums. She has held key roles in the organisation of national conferences. In 1997,A/Professor Loughland established the Schizophrenia Research Institute’s Register (SRR) and is a founding member of the Hunter Medical Research Institute’s Volunteer Research Register (HMRI-VRR) established in 2003. These two resources engage the community in medical research by allowing volunteers to participate in research projects in their local area. Medical researchers are able to access these resources to recruit participants for their projects. To date, these two resources have supported over 400 research projects, and in the process reduced research costs and inform the public about medical research outcomes. Following on the success of the Register, A/Professor Loughland and collaborators obtained funding (The Percy Baxter Charitable Foundation; Australian Rotary Health Research Fund Research Grant) to establish the Hunter DNA Bank for Schizophrenia and Allied Disorder in 2003. More recently, A/Professor Loughland and collaborators established the Australian Schizophrenia Research Bank (ASRB), which provides a national facility for genetic research into schizophrenia. NHMRC Enabling Grant (ID386500 - $1.75 M) and Pratt Foundation ($1.5M) funding was successfully obtained to establish the ASRB, which expands, enriches and links existing SRI programs of infrastructure to provide a national not-for-profit resource to support a wide spectrum of Australian and international schizophrenia research projects.

A/Professor Loughland currently manages the ASRB and is responsible for overseeing recruitment, clinical assessment, neuropsychological measurement, MRI/DTI brain scanning and blood sample collection in people with schizophrenia and healthy controls. This unique resource has drawn significant national and international scientific attention and not only makes a valuable contribution to Australian medical research, but to the broader community through the provision of educational information. A/Professor Loughland has appeared on several national television programs to discuss her research including ‘Sunrise’, ‘Foxtel News’ and current affairs programs such as ‘Today Extra’, and been interviewed several times on national and local radio.

Research Expertise
A/Prof. Loughland is an established researcher with a strong track record in investigating visuo-cognitive deficits in schizophrenia, particularly face emotion processing deficits, and developing remediation programs to reduce the impact of deficits on people's interpersonal and social functioning. A/Prof. Loughland has extended this research to examine how women with mental health disorders process infant face emotion to investigate issues around parenting and child mental health and wellbeing. In addition to this research, A/Prof. Loughland has been involved in the development and management of a number of biobank facilities including the Australian Schizophrenia Research Biobank (ASRB) which holds clinical neuropsychological, fMRI/DTI and genetic data collected from volunteers with schizophrenia and matched controls. This facility has supported over 80 schizophrenia related projects and helps raise awareness about the disorder within the community through research participation and information dissemination. More recently, A/Prof. Loughland and collaborators have developed a communication skills training package called ComPsych to provide core communication skills training to mental health professional for use in psychiatric care. Research is currently being undertaken to evaluate the utility and validity of the ComPsych program in clinical settings with the aim of improving practitioner-patient outcomes for people with a mental illness.

Teaching Expertise
A/Prof. Loughland supervisors students in medicine and psychology, and has provided courses in personality and individual diffierences, clinical assessment and data management, and abnormal psychology. A/Prof. Loughland RHD students are currently undertaking research in face processing in people with schizophrenia, psychopathy, post-natal depression,and borderline personality disorder. Students are also working in studies investigating parenting and infant face perception, the perception and experiences of medical research volunteers, and the evaluation of communication skills training programs in psychiatry.

Administrative Expertise
A/Prof Loughland is a senior academic with several years experience managing people.

Collaborations
Dr Loughland is a member of several research teams. These include the following: Local Research Collaboration: Priority Centre for Translational Neuroscience and Mental Health Centre for Rural and Remote Research National Research Collaboration: Schizophrenia Research Insititute (SRI) Australian Schizophrenia Research Bank (ASRB) International Research Collaboration: Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium


Qualifications

  • PhD (Science), University of Sydney
  • Bachelor of Arts (Psychology) Honours, Unknown

Keywords

  • Abnormal Psychology
  • Biobanking
  • Communication in medicine
  • Eye tracking
  • Face perception and processing
  • Mental health disorders
  • Parenting
  • Personality and Individual Differences
  • Schizophrenia
  • Social Cognition
  • Viso-cognition

Fields of Research

CodeDescriptionPercentage
110319Psychiatry (incl. Psychotherapy)25
111714Mental Health50

Professional Experience

UON Appointment

DatesTitleOrganisation / Department
1/07/2015 - 31/07/2015Associate ProfessorUniversity of Newcastle
School of Medicine and Public Health
Australia

Academic appointment

DatesTitleOrganisation / Department
1/07/2012 - Associate ProfessorUniversity of Newcastle
Schizophrenia Research Institute, Australia
Australia
1/01/2003 - ConvenorSchizophrenia Research Infrastructure Panel
Australia

Membership

DatesTitleOrganisation / Department
Financial Member - ASPRAustralasian Society for Psychiatric Research
Australia

Awards

Research Award

YearAward
2006HMRI Early Career Research Award
Unknown
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Chapter (1 outputs)

YearCitationAltmetricsLink
2013Schofield PW, Moore T, Loughland C, Lechner-Scott J, 'The Audio Recorded Cognitive Screen (ARCS): A flexible and versatile instrument for clinic or research', Screening Tests, Nova Science, Hauppaugue, NY 111-126 (2013) [B1]
Co-authorsPeter Schofield

Journal article (33 outputs)

YearCitationAltmetricsLink
2015Outram S, Harris G, Kelly B, Bylund CL, Cohen M, Landa Y, et al., ''We didn't have a clue': Family caregivers' experiences of the communication of a diagnosis of schizophrenia', INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY, 61 10-16 (2015)
DOI10.1177/0020764014535751Author URL
Co-authorsSue Outram, Brian Kelly
2015Gelder BM, Loughland CM, Carr VJ, Schofield PW, 'Application of the Audio Recorded Cognitive Screen and its relation to functioning in schizophrenia', Acta Neuropsychiatrica, (2015)

Objective: This study investigated the ability of the Audio Recorded Cognitive Screen (ARCS) to detect cognitive deficit in individuals with schizophrenia, relative to the Mini Mental State Examination (MMSE) and the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS), and explored the associations between the ARCS and functional outcomes. We hypothesised that the ARCS would be able to better discriminate between individuals with schizophrenia and healthy controls than the MMSE, and that ARCS performance would be correlated with measures of social and vocational functioning. Methods: The participants were 19 community-dwelling individuals with schizophrenia or schizoaffective disorder and 19 healthy controls recruited from the Australian Schizophrenia Research Bank (ASRB). Participants completed the ARCS, MMSE, and self-report measures of social and vocational functioning. Clinical and diagnostic data stored by the ASRB were also utilised. Results: The schizophrenia group performed worse than the control group on the ARCS, with memory, t(36)=2.49, p=0.02, 95% CI [-1.84, -18.79] and fluency, t(36)=2.40, p=0.02, 95% CI [-1.87, -22.24] domains being the main discriminating measures. The RBANS also discriminated between the two groups, and ARCS and RBANS total scores were moderately to strongly correlated. There was no difference between the two groups on the MMSE after controlling for demographic variables. ARCS performance was associated with employment status [¿2(1)=7.16, p=0.007]. Conclusion: The ARCS may be sensitive to the cognitive deficits in outpatients with schizophrenia and an indicator of functional outcomes in this population.

DOI10.1017/neu.2015.19
Co-authorsPeter Schofield
2014Ripke S, Neale BM, Corvin A, Walters JTR, Farh K-H, Holmans PA, et al., 'Biological insights from 108 schizophrenia-associated genetic loci', Nature, 511 421-427 (2014) [C1]

Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain, providing biological plausibility for the findings. Many findings have the potential to provide entirely new insights into aetiology, but associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia. © 2014 Macmillan Publishers Limited. All rights reserved.

DOI10.1038/nature13595
CitationsScopus - 184Web of Science - 138
Co-authorsRodney Scott, Pat Michie, Ulrich Schall, Frans Henskens
2014Elliot R-L, Campbell L, Hunter M, Cooper G, Melville J, McCabe K, et al., 'WHEN I LOOK INTO MY BABY'S EYES... INFANT EMOTION RECOGNITION BY MOTHERS WITH BORDERLINE PERSONALITY DISORDER', INFANT MENTAL HEALTH JOURNAL, 35 21-32 (2014) [C1]
DOI10.1002/imhj.21426Author URL
CitationsWeb of Science - 1
Co-authorsLinda E Campbell, Mick Hunter
2014Outram S, Harris G, Kelly B, Cohen M, Sandhu H, Vamos M, et al., 'Communicating a Schizophrenia Diagnosis to Patients and Families: A Qualitative Study of Mental Health Clinicians', PSYCHIATRIC SERVICES, 65 551-554 (2014) [C1]
DOI10.1176/appi.ps.201300202Author URL
CitationsScopus - 1Web of Science - 2
Co-authorsBrian Kelly, Sue Outram
2014McCabe KL, Atkinson RJ, Cooper G, Melville JL, Harris J, Schall U, et al., 'Pre-pulse inhibition and antisaccade performance indicate impaired attention modulation of cognitive inhibition in 22q11.2 deletion syndrome (22q11DS)', Journal of Neurodevelopmental Disorders, 6 (2014) [C1]

Background: 22q11.2 deletion syndrome (22q11DS) is associated with a number of physical anomalies and neuropsychological deficits including impairments in executive and sensorimotor function. It is estimated that 25% of children with 22q11DS will develop schizophrenia and other psychotic disorders later in life. Evidence of genetic transmission of information processing deficits in schizophrenia suggests performance in 22q11DS individuals will enhance understanding of the neurobiological and genetic substrates associated with information processing. In this report, we examine information processing in 22q11DS using measures of startle eyeblink modification and antisaccade inhibition to explore similarities with schizophrenia and associations with neurocognitive performance. Methods: Startle modification (passive and active tasks; 120- and 480-ms pre-pulse intervals) and antisaccade inhibition were measured in 25 individuals with genetically confirmed 22q11DS and 30 healthy control subjects. Results: Individuals with 22q1 1DS exhibited increased antisaccade error as well as some evidence (trend-level effect) of impaired sensorimotor gating during the active condition, suggesting a dysfunction in controlled attentional processing, rather than a pre-attentive dysfunction using this paradigm. Conclusions: The findings from the present study show similarities with previous studies in clinical populations associated with 22q11DS such as schizophrenia that may indicate shared dysfunction of inhibition pathways in these groups.

DOI10.1186/1866-1955-6-38
CitationsScopus - 1
Co-authorsLinda E Campbell, Ulrich Schall, Renate Thienel
2013Terwisscha van Scheltinga AF, Bakker SC, van Haren NEM, Derks EM, Buizer-Voskamp JE, Boos HBM, et al., 'Genetic Schizophrenia Risk Variants Jointly Modulate Total Brain and White Matter Volume', Biological Psychiatry, 73 525-531 (2013) [C1]
DOI10.1016/j.biopsych.2012.08.017
CitationsScopus - 23
Co-authorsPat Michie, Frans Henskens, Rodney Scott, Ulrich Schall
2013Van Scheltinga AFT, Bakker SC, Van Haren NEM, Derks EM, Buizer-Voskamp JE, Cahn W, et al., 'Schizophrenia genetic variants are not associated with intelligence', Psychological Medicine, 43 2563-2570 (2013) [C1]

Background Schizophrenia is associated with lower pre-morbid intelligence (IQ) in addition to (pre-morbid) cognitive decline. Both schizophrenia and IQ are highly heritable traits. Therefore, we hypothesized that genetic variants associated with schizophrenia, including copy number variants (CNVs) and a polygenic schizophrenia (risk) score (PSS), may influence intelligence. Method IQ was estimated with the Wechsler Adult Intelligence Scale (WAIS). CNVs were determined from single nucleotide polymorphism (SNP) data using the QuantiSNP and PennCNV algorithms. For the PSS, odds ratios for genome-wide SNP data were calculated in a sample collected by the Psychiatric Genome-Wide Association Study (GWAS) Consortium (8690 schizophrenia patients and 11 831 controls). These were used to calculate individual PSSs in our independent sample of 350 schizophrenia patients and 322 healthy controls. Results Although significantly more genes were disrupted by deletions in schizophrenia patients compared to controls (p = 0.009), there was no effect of CNV measures on IQ. The PSS was associated with disease status (R 2 = 0.055, p = 2.1 × 10 -7) and with IQ in the entire sample (R 2 = 0.018, p = 0.0008) but the effect on IQ disappeared after correction for disease status. Conclusions Our data suggest that rare and common schizophrenia-associated variants do not explain the variation in IQ in healthy subjects or in schizophrenia patients. Thus, reductions in IQ in schizophrenia patients may be secondary to other processes related to schizophrenia risk. © Cambridge University Press 2013.

DOI10.1017/S0033291713000196
CitationsScopus - 12
Co-authorsRodney Scott, Ulrich Schall, Frans Henskens, Pat Michie
2013McCabe KL, Melville JL, Rich D, Strutt PA, Cooper G, Loughland CM, et al., 'Divergent Patterns of Social Cognition Performance in Autism and 22q11.2 Deletion Syndrome (22q11DS)', JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 43 1926-1934 (2013) [C1]
DOI10.1007/s10803-012-1742-2Author URL
CitationsScopus - 2Web of Science - 3
Co-authorsUlrich Schall, Linda E Campbell
2013Schork AJ, Thompson WK, Pham P, Torkamani A, Roddey JC, Sullivan PF, et al., 'All SNPs Are Not Created Equal: Genome-Wide Association Studies Reveal a Consistent Pattern of Enrichment among Functionally Annotated SNPs', PLOS GENETICS, 9 (2013) [C1]
DOI10.1371/journal.pgen.1003449Author URL
CitationsScopus - 41Web of Science - 40
Co-authorsUlrich Schall, Rodney Scott, Pat Michie, Frans Henskens
2012McCabe KL, Maloney EA, Stain HJ, Loughland CM, Carr VJ, 'Relationship between childhood adversity and clinical and cognitive features in schizophrenia', Journal of Psychiatric Research, 46 600-607 (2012) [C1]
CitationsScopus - 10Web of Science - 10
Co-authorsHelen Stain
2011De Ville M, Baker AL, Lewin TJ, Bucci S, Loughland CM, 'Associations between substance use, neuropsychological functioning and treatment response in psychosis', Psychiatry Research, 186 190-196 (2011) [C1]
DOI10.1016/j.psychres.2010.08.025
CitationsScopus - 1Web of Science - 1
Co-authorsAmanda Baker, Terry Lewin
2011McCabe KL, Rich D, Loughland CM, Schall UA, Campbell LE, 'Visual scanpath abnormalities in 22q11.2 deletion syndrome: Is this a face specific deficit?', Psychiatry Research, 189 292-298 (2011) [C1]
CitationsScopus - 6Web of Science - 7
Co-authorsUlrich Schall, Linda E Campbell
2011Gwas Consortium, Henskens FA, Loughland CM, Michie PT, Schall UA, Scott R, 'Genome-wide association study identifies five new schizophrenia loci', Nature Genetics, 43 969-U77 (2011) [C1]
CitationsScopus - 619Web of Science - 385
Co-authorsFrans Henskens, Pat Michie, Rodney Scott, Ulrich Schall
2010Loughland CM, Draganic D, McCabe KL, Richards JM, Nasir MA, Allen J, et al., 'Australian Schizophrenia Research Bank: A database of comprehensive clinical, endophenotypic and genetic data for aetiological studies of schizophrenia', Australian and New Zealand Journal of Psychiatry, 44 1029-1035 (2010) [C1]
DOI10.3109/00048674.2010.501758
CitationsWeb of Science - 19
Co-authorsRodney Scott, Pat Michie, Paul Tooney, Frans Henskens, Ulrich Schall
2010Campbell LE, McCabe KL, Leadbeater KE, Schall UA, Loughland CM, Rich D, 'Visual scanning of faces in 22q11.2 deletion syndrome: Attention to the mouth or the eyes?', Psychiatry Research, 177 211-215 (2010) [C1]
DOI10.1016/j.psychres.2009.06.007
CitationsScopus - 12Web of Science - 13
Co-authorsLinda E Campbell, Ulrich Schall
2010Loughland CM, Allen J, Gianacas L, Schofield PW, Lewin TJ, Hunter M, Carr VJ, 'Brief neuropsychological profiles in psychosis: A pilot study using the Audio Recorded Cognitive Screen (ARCS)', Acta Neuropsychiatrica, 22 243-252 (2010) [C1]
DOI10.1111/j.1601-5215.2010.00492.x
CitationsScopus - 4Web of Science - 3
Co-authorsPeter Schofield, Mick Hunter, Terry Lewin
2009Loughland CM, Lawrence G, Allen J, Hunter M, Lewin TJ, Oud NE, Carr VJ, 'Aggression and trauma experiences among carer-relatives of people with psychosis', Social Psychiatry and Psychiatric Epidemiology, 44 1031-1040 (2009) [C1]
DOI10.1007/s00127-009-0025-5
CitationsScopus - 10Web of Science - 9
Co-authorsTerry Lewin, Mick Hunter
2009Morris RW, Weickert CS, Loughland CM, 'Emotional face processing in schizophrenia', Current Opinion in Psychiatry, 22 140-146 (2009) [C1]
DOI10.1097/yco.0b013e328324f895
CitationsScopus - 60Web of Science - 57
2007Loughland CM, Lewin TJ, Carr VJ, Sheedy J, Harris AW, 'RBANS neuropsychological profiles within schizophrenia samples recruited from non-clinical settings', Schizophrenia Research, 89 232-242 (2007) [C1]
DOI10.1016/j.schres.2006.08.022
CitationsScopus - 21Web of Science - 21
Co-authorsTerry Lewin
2004Loughland CM, Carr VJ, Lewin TJ, Barnard RE, Chapman JL, Walton JM, 'Potential sampling and recruitment source impacts in schizophrenia research', Psychiatry Research: an international journal for rapid communication, 125 117-127 (2004) [C1]
DOI10.1016/j.psychres.2003.11.002
CitationsScopus - 15Web of Science - 14
Co-authorsTerry Lewin
2004Loughland CM, Williams LM, Harris A, 'Visual scanpath dysfunction in first-degree relatives of schizophrenia probands: evidence for a vunerability marker?', Schizophrenia Research, 67 11-21 (2004) [C1]
DOI10.1016/S0920-9964(03)00094-X
CitationsScopus - 55Web of Science - 53
2003Williams LM, Loughland CM, Green MJ, Harris AWF, Gordon E, 'Emotion perception in schizophrenia: An eye movement study comparing the effectiveness of risperidone vs. haloperidol', Psychiatry Research, 120 13-27 (2003) [C1]
DOI10.1016/s0165-1781(03)00166-5
CitationsScopus - 46Web of Science - 39
2003Lee KH, Harris AW, Loughland CM, Williams LM, 'The five symptom dimensions and depression in schizophrenia', PSYCHOPATHOLOGY, 36 226-233 (2003)
DOI10.1159/000073447Author URL
CitationsScopus - 28Web of Science - 26
2002Loughland CM, Williams L, Gordon E, 'Visual scanpaths to positive and negative facial emotions in an outpatient schizophrenia sample', Schizophrenia Research, 55 159-170 (2002) [C1]
CitationsScopus - 114Web of Science - 101
2002Loughland CM, Williams L, Gordon E, 'Schizophrenia and Affective Disorder Show Different Visual Scanning Behaviour for Faces: A Trait versus State-Based Distinction?', Biological Psychiatry, 52 338-348 (2002) [C1]
CitationsScopus - 82Web of Science - 73
2001Loughland CM, Carr VJ, Lewin T, 'The NISAD Schizophrenia Research Register: why do we need a database of schizophrenia volunteers?', Australian and New Zealand Journal of Psychiatry, 35 660-667 (2001) [C1]
CitationsScopus - 25Web of Science - 23
Co-authorsTerry Lewin
2001Lee KH, Williams LM, Loughland CM, Davidson DJ, Gordon E, 'Syndromes of schizophrenia and smooth-pursuit eye movement dysfunction', PSYCHIATRY RESEARCH, 101 11-21 (2001)
DOI10.1016/S0165-1781(00)00242-0Author URL
CitationsScopus - 23Web of Science - 20
2001Williams LM, Senior C, David AS, Loughland CM, Gordon E, 'In search of the "Duchenne smile": Evidence from eye movements', JOURNAL OF PSYCHOPHYSIOLOGY, 15 122-127 (2001)
DOI10.1027//0269-8803.15.2.122Author URL
CitationsScopus - 24Web of Science - 21
2001Carr VJ, Lewin TJ, Loughland CM, Barnard RE, Johnston PJ, Chapman JL, Walton JM, 'Does the source of sampling make a difference in schizophrenia research?', SCHIZOPHRENIA RESEARCH, 49 258-258 (2001)
Author URL
Co-authorsTerry Lewin
1999Williams LM, Loughland CM, Gordon E, 'Visual scanpaths and recognition of positive and negative facial emotions in schizophrenia', SCHIZOPHRENIA RESEARCH, 36 268-268 (1999)
Author URL
CitationsWeb of Science - 2
1999Williams LM, Loughland CM, Gordon E, Davidson D, 'Visual scanpaths in schizophrenia: is there a deficit in face recognition?', SCHIZOPHRENIA RESEARCH, 40 189-199 (1999)
DOI10.1016/S0920-9964(99)00056-0Author URL
CitationsScopus - 90Web of Science - 84
1996Loughland C, Williams L, 'A cluster analytic study of schizotypal trait dimensions', Personality and Individual Differences, 23 877-883 (1996) [C1]
CitationsScopus - 18Web of Science - 15
Show 30 more journal articles

Conference (47 outputs)

YearCitationAltmetricsLink
2013Phare D, Gu N, Williams T, Loughland C, 'A Semiotic Framework to Understand How Signs in a Collective Design Task Convey Information: A Pilot Study of Design in an Open Crowd Context', Cutting Edge: 47th International Conference of the Architectural Science Association, Hong Kong (2013) [E1]
Co-authorsTony Williams, Ning Gu
2013Loughland C, Outram S, Kelly B, Cohen M, 'COMMUNICATING A DIAGNOSIS OF SCHIZOPHRENIA', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013) [E3]
Author URL
Co-authorsSue Outram, Brian Kelly
2013Loughland CM, Kelly B, Outram S, Harris G, Cohan M, Sandhu H, et al., 'Patients' experiences and perceptions of a diagnosis of schizophrenia', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013) [E3]
Author URL
Co-authorsBrian Kelly, Sue Outram
2013Outram S, Kelly B, Loughland CM, Harris G, Cohan M, Sandhu H, et al., 'Communicating a diagnosis of schizophrenia: Experiences and perceptions of carers', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013) [E3]
Author URL
Co-authorsBrian Kelly, Sue Outram
2013Kelly B, Outram S, Loughland CM, Harris G, Kelly F, Cohan M, et al., 'Communicating a diagnosis of schizophrenia: Experiences and perceptions of mental health clinicians', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013) [E3]
Author URL
Co-authorsSue Outram, Brian Kelly
2013Cohan M, Sandhu H, Vamos M, Ditton-Phare P, Kelly F, Kelly B, et al., 'Communication skills training in psychiatry: An Australia experience', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013) [E3]
Author URL
Co-authorsSue Outram, Brian Kelly
2012Paul DJ, Henskens FA, Loughland CM, McCabe KL, Bridge JE, Duffy L, et al., 'Issues preventing the migration of the Australian Schizophrenia Research Bank to the cloud', Proceedings of the IADIS International Conference On Internet Technologies & Society, Perth, Australia (2012) [E1]
Co-authorsFrans Henskens, Pat Michie, Rodney Scott, Ulrich Schall
2012Paul DJ, Henskens FA, Loughland CM, Bridge JE, McCabe KL, Carr VJ, et al., 'IT development and management of a live e-research system: Experiences with the Australian Schizophrenia Research Bank', HEALTHINF 2012 - Proceedings of the International Conference on Health Informatics, Vilamoura, Algarve (2012) [E1]
Co-authorsFrans Henskens, Pat Michie, Rodney Scott, Ulrich Schall
2012Loughland CM, McCabe KL, Bridge JE, Henskens FA, Catts S, Jablensky A, et al., 'The Australian Schizophrenia Research Biobank (ASRB): An audit of the first five years of recruitment resource access', Schizophrenia Research, Florence, Italy (2012) [E3]
Co-authorsRodney Scott, Ulrich Schall, Pat Michie, Paul Tooney, Frans Henskens
2012Henskens FA, Paul DJ, Loughland CM, Bridge JE, McCabe KL, Catts S, et al., 'The Australian Schizophrenia Research Biobank (ASRB): IT development and management of a live e-research system', Schizophrenia Research, Florence, Italy (2012) [E3]
Co-authorsUlrich Schall, Pat Michie, Paul Tooney, Frans Henskens
2011McCabe K, McCabe K, Loughland CM, Hunter M, Lewin T, Carr VJ, 'A BOTTOM-UP BIOFEEDBACK REMEDIATION IMPROVES EMOTION RECOGNITION IN SCHIZOPHRENIA: EVIDENCE FROM A VISUAL SCAN PATH PILOT STUDY', SCHIZOPHRENIA BULLETIN, Colorado Springs, CO (2011) [E3]
Author URL
Co-authorsTerry Lewin, Mick Hunter
2011Maloney E, McCabe KL, Bridge J, Stain HJ, Loughland CM, Carr V, 'Childhood adversity in schizophrenia: Neurocognitive and clinical correlates from the Australian schizophrenia research bank (ASRB)', Schizophrenia Bulletin, Colorado Springs, CO (2011) [E3]
Co-authorsHelen Stain
2011Loughland CM, McCabe KL, Catts S, Jablensky A, Henskens FA, Michie PT, et al., 'The Australian Schizophrenia Research Bank (ASRB): The first 550 schizophrenia sample profile', Schizophrenia Bulletin, Schizophrenia Bulletin (2011) [E3]
Co-authorsPaul Tooney, Frans Henskens, Ulrich Schall, Pat Michie, Rodney Scott
2010McCabe KL, Bridge J, Loughland CM, Carr V, 'Childhood adversity in a schizophrenia population: Data from the Australian Schizophrenia Research Bank (ASRB)', Australian & New Zealand Journal of Psychiatry, Sydney, NSW (2010) [E3]
2010McCabe KL, Loughland CM, Hunter M, Lewin TJ, Carr VJ, 'Remediation of emotion recognition in schizophrenia using biofeedback: Evdience from a visual scan path pilot study', Australian & New Zealand Journal of Psychiatry, Sydney, NSW (2010) [E3]
Co-authorsMick Hunter, Terry Lewin
2010Paulik G, Atkinson RJ, Carr V, Clark S, Curtis J, Langdon R, et al., 'Minds in transition (MINT): A prospective study examining neurocognitive correlates of transition from ultra-high risk mental state to schizophrenia', Australian & New Zealand Journal of Psychiatry, Sydney, NSW (2010) [E3]
Co-authorsHelen Stain, Pat Michie, Juanita Todd, Ulrich Schall, Renate Thienel, Paul Tooney
2010Carr V, Loughland CM, McCabe KL, Nasir A, Stan C, Jablensky A, et al., 'The Australian Schizophrenia Research Bank (ASRB): Demographic, clinical and neuropsychological profiles for the first 500 participants with schizophrenia', Schizophrenia Research, Florence, Italy (2010) [E3]
Co-authorsPat Michie, Ulrich Schall, Frans Henskens, Rodney Scott
2010Henskens FA, Carr VJ, Catts S, Jablensky A, Michie PT, Loughland CM, et al., 'The Australian Schizophrenia Research Bank (ASRB): An example of eresearch', Schizophrenia Research, Florence, Italy (2010) [E3]
Co-authorsPat Michie, Rodney Scott, Ulrich Schall, Frans Henskens
2010McCabe KL, Loughland CM, Hunter M, Lewin TJ, Carr VJ, 'A bottom-up biofeedback remediation improves emotion recognition in schizophrenia: Evidence from a visual scan path pilot study', Schizophrenia Research, Florence, Italy (2010) [E3]
Co-authorsMick Hunter, Terry Lewin
2010McCabe KL, Loughland CM, Nasir MA, Catts S, Jablensky A, Henskens FA, et al., 'The Australian Schizophrenia Research Bank (ASRB): Quality assurance and control for a comprehensive clinical, neuropsychological, genetic and neuroimaging database for researchers', Schizophrenia Research, Florence, Italy (2010) [E3]
Co-authorsRodney Scott, Pat Michie, Frans Henskens, Ulrich Schall
2010Ayre M, Loughland CM, Bore MR, Baker AL, 'The relationship between social problem-solving and emotional regulation in people with schizophrenia', Schizophrenia Research, Florence, Italy (2010) [E3]
Co-authorsMiles Bore, Amanda Baker
2009Henskens FA, Carr VJ, Catts SV, Jablenski A, Michie PT, Loughland CM, et al., 'An Example of eResearch: The Australian Schizophrenia Research Bank', Proceedings eResearch 2009, Sydney, Australia (2009)
Co-authorsFrans Henskens, Pat Michie, Rodney Scott, Ulrich Schall
2009Henskens FA, Loughland CM, Aphale MS, Paul D, Richards JM, Rasser P, et al., 'it support for the australian schizophrenia research bank', HEALTHINF 2009 - Proceedings of the 2nd International Conference on Health Informatics, Oporto, PORTUGAL (2009) [E1]
Co-authorsRodney Scott, Ulrich Schall, Pat Michie, Frans Henskens
2009Carr VJ, Loughland CM, Catts S, Henskens FA, Jablensky A, Michie PT, et al., 'A database of comprehensive clinical, endophenotypic and genetic data for aetiological studies of schizophrenia', Schizophrenia Bulletin, San Diego, CA (2009) [E3]
DOI10.1093/schbul/sbn173
Co-authorsUlrich Schall, Frans Henskens, Pat Michie, Rodney Scott
2009Loughland CM, Richards J, Aphale M, Henskens FA, Carr VJ, Catts SV, et al., 'The Australian Schizophrenia Research Bank (ASRB): The development of an electronically delivered clinical assessment battery', Schizophrenia Bulletin, San Diego, CA (2009) [E3]
DOI10.3109/00048674.2010.501758
CitationsScopus - 23
Co-authorsTerry Lewin, Frans Henskens, Pat Michie, Rodney Scott, Ulrich Schall
2008Carr VJ, Loughland CM, Catts SV, Henskens FA, Jablensky A, Michie PT, et al., 'A progress report on the Australian Schizophrenia Research Bank', Australian and New Zealand Journal of Psychiatry, Lorne, VIC (2008) [E3]
Co-authorsFrans Henskens, Pat Michie, Ulrich Schall, Rodney Scott
2008Campbell LE, McCabe KL, Leadbeater KE, Rich D, Schall UA, Loughland CM, 'Visual scan paths in young adults with velo-cardio-facial syndrome (22Q11.2 Deletion Syndrome)', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authorsLinda E Campbell, Ulrich Schall
2008Richards J, Loughland CM, Aphale M, Henskens FA, Carr VJ, Catts SV, et al., 'The Australian Schizophrenia Research Bank (ASRB) computer-based clinical assessment software (CAS): Development and application', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authorsPat Michie, Rodney Scott, Frans Henskens, Ulrich Schall, Terry Lewin
2008Thornton LK, Baker AL, Johnson MP, Loughland CM, Lewin TJ, Kay-Lambkin FJ, 'An exploration of drug attitudes and knowledge among people with psychotic disorders', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authorsMartin Johnson, Amanda Baker, F Kaylambkin, Terry Lewin
2008Loughland CM, McCabe KL, Johnston PJ, Lewin TJ, Carr VJ, 'Performance on the tile matrix task provides further evidence of visuo-cognitive disturbances in the first-degree relatives of schizophrenia patients', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authorsTerry Lewin
2008McCabe KL, Loughland CM, Hunter M, Lewin TJ, Carr VJ, 'Randomised control trial of emotion perception remediation among people with schizophrenia', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authorsTerry Lewin, Mick Hunter
2008Sly K, Loughland CM, Lewin TJ, Hunter M, 'Facial expression processing in schizophrenia: Associations with psychopathy, syptomatology and emotion recognition', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authorsTerry Lewin, Mick Hunter
2008Campbell LE, McCabe KL, Cruickshank L, Leadbeater KE, Schall UA, Karayanidis F, Loughland CM, 'Social cognitive skills and visual scan paths in children and young adults with velo-cardio-facial syndrom (22Q11.2 Deletion Syndrome)', Australian and New Zealand Journal of Psychiatry, Lorne, VIC (2008) [E3]
DOI10.1080/00048670802441844
Co-authorsFrini Karayanidis, Linda E Campbell, Ulrich Schall
2007McCabe KL, Loughland CM, Cohen M, Hunter M, Lewin TJ, Carr VJ, 'Remediation of facial affect decoding and visual scanpath deficits in schizophrenia', Schizophrenia Bulletin, Colorado Springs, Colorado (2007) [E3]
CitationsWeb of Science - 1
Co-authorsTerry Lewin, Mick Hunter
2007Loughland CM, McCabe KL, Hunter M, Lewin TJ, Carr VJ, 'Are facial information retention/integration deficits in first-degree relatives of schizophrenia patients further evidence of a vulnerability marker?', Schizophrenia Bulletin, Colorado Springs, Colorado (2007) [E3]
Co-authorsTerry Lewin, Mick Hunter
2007Lewin TJ, Loughland CM, Carr VJ, Baker A, 'A recruitment source impacts in schizophrenia research', Schizophrenia Bulletin, Colorado Springs, Colorado (2007) [E3]
Co-authorsTerry Lewin, Amanda Baker
2007Carr VJ, Loughland CM, Draganic B, Lewin TJ, Schall UA, Scott R, et al., 'The Australian Schizophrenia Research Bank (ASRB)', Schizophrenia Bulletin (Abstracts of the 11th International Congress on Schizophrenia Research), Colorado Springs, Colorado (2007) [E3]
Co-authorsTerry Lewin, Rodney Scott, Frans Henskens, Pat Michie, Ulrich Schall
2007Loughland CM, Carr VJ, Michie PT, Stain HJ, Badcock J, Jablenski A, et al., 'The national recruitment and assessment of people with schizophrenia: The ASRB experience', Australian and New Zealand Journal of Psychiatry, Melbourne (2007) [E3]
Co-authorsUlrich Schall, Pat Michie, Helen Stain
2007Loughland C, Michie PM, Stain H, Babcock J, Jablensky A, Draganic D, et al., 'The national recruitment and assessment of people with schizophrenia: The ASRB experience', Proceedings ASPR 2007, Melbourne, Australia (2007)
Co-authorsFrans Henskens, Pat Michie, Rodney Scott, Ulrich Schall, Terry Lewin
2006Loughland CM, McCabe KL, Johnston PJ, Lewin TJ, Carr VJ, 'Are visuo-cognitive disturbances in first degree relatives of schizophrenia patients evidence for a vulnerability marker? (Poster presentation)', Abstracts from the XIIIth Biennial Winter Workshop on Schizophrenia Research (Schizophrenia Research (Vol 81, Sup 1)), Davos, Switzerland (2006) [E3]
Co-authorsTerry Lewin
2006Loughland CM, McCabe KL, Johnston PJ, Lewin (Ext) T, Carr VJ, 'Are visuo-cognitive disturbances infirst degree relatives of schizophrenia patients evidence for a vulnerabliity marker', Australan & New Zealand Journal of Psychiatry, Fremantle WA (2006) [E3]
Co-authorsTerry Lewin
2006McCabe KL, Loughland CM, Cohen M, Johnston PJ, Hunter M, Lewin TJ, Carr VJ, 'Remediation of facial affect decoding and visual scanpath deficits in schizophrenia', Australian and New Zealand Journal of Psychiatry, Fremantle, Western Australia (2006) [E3]
Co-authorsMick Hunter, Terry Lewin
2005Lawrence G, Loughland CM, Lewin (Ext) T, Carr VJ, 'NISAD Schizophrenia research register: characterizing the first-degree relative volunteers', Abstracts for The Royal Australian & NZ College of Psychiatrists Joint CINP/ASPR Scientific Meeting, Brisbane (2005) [E3]
2005Russell SH, Loughland CM, Tooney PA, Scott R, Carr VJ, 'The Hunter DNA bank for schizophrenia and allied disorders: A unique Australian Resource facilitating genetic research into mental illness', Abstracts for The Royal Australian & NZ College of Psychiatrists Joint CINP/ASPR Scientific Meeting, Brisbane (2005) [E3]
Co-authorsPaul Tooney, Rodney Scott
2005Loughland CM, McCabe KL, Johnston PJ, Lewin (Ext) T, Carr VJ, 'Visuo-cognitive deficits in schizophrenia and first-degree relatives', Abstracts of The Royal Australian & NZ College of Psychiatrists Joint CINP/ASPR Scientific Meeting, Brisbane (2005) [E3]
2005Loughland CM, Lewin TJ, Carr VJ, Harris AW, 'RBANS neuropsychological profiles within schizophrenia samples recruited from non-treatment settings', SCHIZOPHRENIA BULLETIN, Savannah, GA (2005)
Author URL
Co-authorsTerry Lewin
2003Loughland CM, Williams LM, Gordon E, 'Schizophrenia and affective disorder show different visual scanpath patterns to faces and facial expressions: Is this a trait versus state-based distinction?', SCHIZOPHRENIA RESEARCH, COLORADO SPINGS, COLORADO (2003)
DOI10.1016/S0920-9964(03)80413-9Author URL
Show 44 more conferences
Edit

Grants and Funding

Summary

Number of grants19
Total funding$1,475,915

Click on a grant title below to expand the full details for that specific grant.


20152 grants / $478,000

Associate Professor of Translational Research in Mental Health $241,000

Funding body: Hunter New England Local Health District

Funding bodyHunter New England Local Health District
Project TeamDoctor Carmel Loughland, Conjoint Associate Professor Martin Cohen
SchemeResearch Funds
RoleLead
Funding Start2015
Funding Finish2015
GNoG1500836
Type Of FundingOther Public Sector - State
Category2OPS
UONY

Clinical Advisor to the Mental Health: Hospital to Community Initiative$237,000

Funding body: NSW Health

Funding bodyNSW Health
Project TeamDoctor Carmel Loughland
SchemeResearch Funds
RoleLead
Funding Start2015
Funding Finish2015
GNoG1500837
Type Of FundingOther Public Sector - State
Category2OPS
UONY

20141 grants / $2,000

Joint Ottawa CCME Conference 2014, Ottawa Canada, 25-29 April 2014$2,000

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding bodyUniversity of Newcastle - Faculty of Health and Medicine
Project TeamDoctor Carmel Loughland
SchemeTravel Grant
RoleLead
Funding Start2014
Funding Finish2014
GNoG1400493
Type Of FundingInternal
CategoryINTE
UONY

20131 grants / $2,000

International Congress on Schizophrenia Research (ICOSR), JW Marriott Hotel, Orlando Great Lakes, Florida USA, 21 - 25 April 2013$2,000

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding bodyUniversity of Newcastle - Faculty of Health and Medicine
Project TeamDoctor Carmel Loughland
SchemeTravel Grant
RoleLead
Funding Start2013
Funding Finish2013
GNoG1300180
Type Of FundingInternal
CategoryINTE
UONY

20124 grants / $112,000

Technical officer to support the Australian Schizophrenia Research Bank (ASRB)$70,000

Funding body: Schizophrenia Research Institute

Funding bodySchizophrenia Research Institute
Project TeamProfessor Rodney Scott, Doctor Carmel Loughland
SchemeResearch Grant
RoleInvestigator
Funding Start2012
Funding Finish2012
GNoG1200834
Type Of FundingGrant - Aust Non Government
Category3AFG
UONY

Testing for N-methyl-D-aspartate (NMDA) receptor antibodies in a large Australian cohort of schizophrenia patients$30,000

Funding body: Hunter Medical Research Institute

Funding bodyHunter Medical Research Institute
Project TeamAssociate Professor Paul Tooney, Mr Paul Rasser, Mr TIM Ehlkes, Emeritus Professor Patricia Michie, Professor Ulli Schall, Doctor Carmel Loughland
SchemeProject Grant
RoleInvestigator
Funding Start2012
Funding Finish2012
GNoG1200854
Type Of FundingContract - Aust Non Government
Category3AFC
UONY

Testing for N-methyl-D-aspartate (NMDA) receptor antibodies in a large Australian cohort of schizophrenia patients$10,000

Funding body: Schizophrenia Research Institute

Funding bodySchizophrenia Research Institute
Project TeamAssociate Professor Paul Tooney, Associate Professor Ute Vollmer-Conna, Mr Paul Rasser, Mr TIM Ehlkes, Emeritus Professor Patricia Michie, Professor Ulli Schall, Doctor Carmel Loughland
SchemeResearch Grant
RoleInvestigator
Funding Start2012
Funding Finish2012
GNoG1201020
Type Of FundingGrant - Aust Non Government
Category3AFG
UONY

3rd Biennial Schizophrenia International Research Society (SIRS), Fortezza de Basso, Florence Italy, 13 - 18 April 2012$2,000

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding bodyUniversity of Newcastle - Faculty of Health and Medicine
Project TeamDoctor Carmel Loughland
SchemeTravel Grant
RoleLead
Funding Start2012
Funding Finish2012
GNoG1200500
Type Of FundingInternal
CategoryINTE
UONY

20111 grants / $51,930

Here's looking at you, kid: Face processing, emotional availability and reflective functioning in mothers with postnatal depression$51,930

Funding body: Hunter Medical Research Institute

Funding bodyHunter Medical Research Institute
Project TeamDoctor Carmel Loughland, Doctor Linda Campbell
SchemeProject Grant
RoleLead
Funding Start2011
Funding Finish2011
GNoG1001024
Type Of FundingContract - Aust Non Government
Category3AFC
UONY

20073 grants / $594,985

Technical Officer to Support the Australian Schizophrenia Research Bank (ASRB)$438,985

Funding body: Schizophrenia Research Institute

Funding bodySchizophrenia Research Institute
Project TeamAssociate Professor Frans Henskens, Doctor Carmel Loughland
SchemeResearch Grant
RoleInvestigator
Funding Start2007
Funding Finish2007
GNoG0187035
Type Of FundingGrant - Aust Non Government
Category3AFG
UONY

HMRI Postdoctoral Fellowship in Youth Mental Health Research$150,000

Funding body: Hunter Medical Research Institute

Funding bodyHunter Medical Research Institute
Project TeamProfessor Ulli Schall, Emeritus Professor Patricia Michie, Associate Professor Paul Tooney, Associate Professor Helen Stain, Doctor Carmel Loughland, Conjoint Professor Vaughan Carr
SchemePostdoctoral Fellowship
RoleInvestigator
Funding Start2007
Funding Finish2007
GNoG0188274
Type Of FundingDonation - Aust Non Government
Category3AFD
UONY

Visuo-cognitive deficits in schizophrenia patients and their first degree relatives$6,000

Funding body: Hunter Medical Research Institute

Funding bodyHunter Medical Research Institute
Project TeamDoctor Carmel Loughland
SchemePULSE Early Career Researcher of the Year Award
RoleLead
Funding Start2007
Funding Finish2007
GNoG0187400
Type Of FundingDonation - Aust Non Government
Category3AFD
UONY

20053 grants / $137,000

Facial expression processing deficits in schizophrenia patients and their biological 1st-degree relatives$70,000

Funding body: Neuroscience Institute of Schizophrenia and Allied Disorders

Funding bodyNeuroscience Institute of Schizophrenia and Allied Disorders
Project TeamMs Kathryn McCabe, Doctor Carmel Loughland, Conjoint Associate Professor Mick Hunter, Mr Patrick Johnston
SchemePostgraduate Research Scholarship
RoleLead
Funding Start2005
Funding Finish2005
GNoG0185368
Type Of FundingDonation - Aust Non Government
Category3AFD
UONY

Schizophrenia DNA Bank.$59,000

Funding body: Australian Rotary Health

Funding bodyAustralian Rotary Health
Project Team
SchemeUnknown
RoleInvestigator
Funding Start2005
Funding Finish2007
GNo
Type Of FundingNot Known
CategoryUNKN
UONY

Remediation of facial affect decoding and visual scanpath deficits in schizophrenia$8,000

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamDoctor Carmel Loughland, Conjoint Associate Professor Martin Cohen, Mr Patrick Johnston, Conjoint Professor Vaughan Carr
SchemeProject Grant
RoleLead
Funding Start2005
Funding Finish2005
GNoG0184792
Type Of FundingInternal
CategoryINTE
UONY

20042 grants / $85,000

Facial expression processing deficits in schizophrenia and their first degree relatives.$48,000

Funding body: National Alliance for Research on Schizophrenia and Depression

Funding bodyNational Alliance for Research on Schizophrenia and Depression
Project Team
SchemeUnknown
RoleLead
Funding Start2004
Funding Finish2005
GNo
Type Of FundingInternational - Non Competitive
Category3IFB
UONY

Technical support for the Hunter DNA Bank for Schizophrenia and Allied Disorders$37,000

Funding body: Hunter Medical Research Institute (HMRI)

Funding bodyHunter Medical Research Institute (HMRI)
Project Team
SchemeUnknown
RoleInvestigator
Funding Start2004
Funding Finish2005
GNo
Type Of FundingExternal
CategoryEXTE
UONY

20032 grants / $13,000

Assessment of somatosensory function in subjects with schizophrenia: touch, pain and axon reflex flare.$11,000

Funding body: University of Newcastle

Funding bodyUniversity of Newcastle
Project TeamConjoint Professor Loris Chahl, Conjoint Professor Vaughan Carr, Associate Professor Paul Tooney, Doctor Carmel Loughland, Professor Mike Calford
SchemeProject Grant
RoleInvestigator
Funding Start2003
Funding Finish2003
GNoG0182466
Type Of FundingInternal
CategoryINTE
UONY

Travel Grant to attend International Congress on Schizophrenia Research, Colorado Springs USA$2,000

Funding body: Ian Potter Foundation

Funding bodyIan Potter Foundation
Project Team
SchemeTravel Grant
RoleLead
Funding Start2003
Funding Finish2003
GNo
Type Of FundingExternal
CategoryEXTE
UONY
Edit

Research Supervision

Current Supervision

CommencedResearch Title / Program / Supervisor Type
2015Understanding Negative Thought Experiences in Healthy Fathers
Behavioural Science, Faculty of Health and Medicine
Co-Supervisor
2015The Symbolism of Antipsychotic Medication and its Impact on Recovery for People Diagnosed with Schizophrenia
General Medicine, Faculty of Health and Medicine
Co-Supervisor
2013A Longitudinal Study of Physical Health in Individuals With Severe Mental Health Problems
General Medicine, Faculty of Health and Medicine
Principal Supervisor
2012Here's Looking at You, Kid: Face Processing, Emotional Availability and Reflective Functioning in Mothers with Postnatal Depression
Psychology, Faculty of Science and Information Technology
Co-Supervisor
2009Facial Expression Processing in Individuals with Schizophrenia: Associations with Psychopathy, Symptomatology amd Emotion Regulation
Psychology, Faculty of Science and Information Technology
Principal Supervisor
2006Visual scanpath impairement in schizophrenia: The role of psychopathy.
Psychology, University of Newcastle
Principal Supervisor
2005Comparison between RBANS and ARCS in a schizophrenia sample.
Psychology, University of Newcastle
Principal Supervisor
2005Visucal scanpath deficits in patients with schizophrenia: The development of a remediation program
Psychology, University of Newcastle
Principal Supervisor
2005Incidents of agreesion and trauma in family members of schizophrenia patients.
Psychology, University of Newcastle
Principal Supervisor

Past Supervision

YearResearch Title / Program / Supervisor Type
2012Face Emotion Processing Deficits in Schizophrenia: Identification and Remediation Utilising Visual Scanpath Technology
Psychiatry, Faculty of Health and Medicine
Principal Supervisor
Edit

News

schizophrenia

Landmark schizophrenia genetic study

July 23, 2014

UON researchers have helped unearth more than 100 genetic variants associated with schizophrenia, after contributing to the largest genome-wide study of the disease ever conducted.

Dr Carmel Loughland

Position

Associate Professor
PR Centre for Translational Neuroscience and Mental Health Research
School of Medicine and Public Health
Faculty of Health and Medicine

Focus area

Public Health

Contact Details

Emailcarmel.loughland@newcastle.edu.au
Phone(02) 4033 5722
Mobile0413000507
Fax(02) 4033 5692

Office

RoomLevel 5, Room 5020
BuildingMcAuley Building
LocationMater Hospital

,
Edit